Demant A/S (OTCMKTS:WILYY) Lowered to Hold Rating by UBS Group

UBS Group downgraded shares of Demant A/S (OTCMKTS:WILYYFree Report) from a strong-buy rating to a hold rating in a research report sent to investors on Wednesday morning,Zacks.com reports.

Other equities research analysts have also issued research reports about the company. Morgan Stanley raised Demant A/S from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, June 23rd. Zacks Research raised shares of Demant A/S to a “hold” rating in a research note on Friday, June 26th. Finally, Sanford C. Bernstein downgraded shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

View Our Latest Analysis on WILYY

Demant A/S Price Performance

Shares of Demant A/S stock opened at $20.66 on Wednesday. The stock’s 50-day moving average is $19.59 and its 200-day moving average is $16.95. Demant A/S has a one year low of $13.45 and a one year high of $20.98. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.00 and a current ratio of 1.36.

Demant A/S Company Profile

(Get Free Report)

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.

Further Reading

Analyst Recommendations for Demant A/S (OTCMKTS:WILYY)

Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.